However, unlike non-small cell lung cancer (NSCLC), where useful markers such as EGFR gene mutation have already been established, the molecular markers regulating sensitivity to EGF/EGFR as well as those targeting VEGF/VEGFR in ESCC are hardly known. The gene discussed is KDR; the disease is esophageal squamous cell carcinoma.